Translate...

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet
Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing.